Tunicates: A vertebrate ancestral source of antitumor compounds

Handbook of Anticancer Drugs from Marine Origin

Volumn , Issue , 2015, Pages 383-395

  Cooper, Edwin L ^a   Albert, Ralph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antitumor compounds; Aplidine; Bioprospecting; Cytoxicity; Trabectedin; Tunicates

Indexed keywords

EID: 84944618723     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-07145-9_18     Document Type: Chapter

References (48)

1. University of California Museum of Paleontology (2006) Introduction to the Urochordata. Http://www.ucmp.berkeley.edu/chordata/urochordata.html. Accessed 29 Sept 2013
2. Cooper EL (2012) Adaptive immunity from prokaryotes to eukaryotes: broader inclusions due to less exclusivity? In: Kanwar JR (ed) Recent advances in immunology to target cancer, inflammation and infections. Tech, Croatia, pp 495-520
3. Parrinello N (1996) Cytotoxic activity of tunicate hemocytes. Prog Mol Subcell Biol 15:190-217
4. Cooper EL, Yao D (2012) Diving for drugs: tunicate anticancer compounds. Drug Discov Today 17 (11-12):636-648
5. Robert J (2010) Comparative study of tumorigenesis and tumor immunity in invertebrates and nonmammalian vertebrates. Dev Comp Immunol 34(9):915-925
6. Kvell K, Cooper EL, Engelmann P et al (2007) Blurring borders: innate immunity with adaptive features. Clin Dev Immunol. Http://www.hindawi.com/journals/jir/2007/083671/abs/
7. Cooper EL, Mansour MH, Negm HI (1996) Marine invertebrate immunodefense responses: molecular and cellular approaches in tunicates. Annu Rev Fish Dis 6:133-149
8. Cooper EL, Parrinello N (2001) Immunodefense in tunicates: cells and molecules. In: The biology of ascidians. Springer, Tokyo, pp 383-391
9. Morandi A, Tosto C, Sartori G, Roberti di Sarsina P (2011) Advent of a link between ayurveda and modern health science: the proceedings of the first international congress on ayurveda, Ayurveda: the meaning of life-awareness, environment, and health March 21-22, 2009
10. Milan, Italy. Evid Based Complement Alternat Med 2011:929-083
11. Liu ML, Chien LY, Tai CJ, Lin KC (2011) Effectiveness of traditional Chinese medicine for liver protection and chemotherapy completion among cancer patients. Evid Based Complement Alternat Med 2011:291-843
12. Watanabe K, Matsuura K, Gao P, Hottenbacher L, Tokunaga H, Nishimura K, Imazu Y, Re- issenweber H, Witt CM (2011) Traditional Japanese kampo medicine: clinical research between modernity and traditional medicine-the state of research and methodological suggestions for the future. Evid Based Complement Alternat Med 2011:513-842
13. Cooper EL, Balamurugan M (2010) Unearthing a source of medicinal molecules. Drug Dis- cov Today 15 (21):966-972
14. Cooper EL (2005) CAM, eCAM, bioprospecting: the twenty first century pyramid. Evid Based Complement Alternat Med 2 (2):125
15. Rinehart KL (2000) Antitumor compounds from tunicates. Med Res Rev 20 (1):1-27
16. Sima P, Vetvicka V (2011) Bioactive substances with anti-neoplastic efficacy from marine invertebrates: bryozoa, Mollusca, Echinodermata and Urochordata. World J Clin Oncol 2 (11):362
17. Tohme R, Darwiche N, Gali-Muhtasib H (2011) A journey under the sea: the quest for marine anti-cancer alkaloids. Molecules 16 (12):9665-9696
18. Mayer A (2013) Marine pharmaceuticals: the preclinical pipeline. Http://marinepharmacol- ogy.midwestern.edu/preclinPipeline.htm. Accessed 15 Oct 2013
19. Tulp M, Bohlin L (2002) Functional versus chemical diversity: is biodiversity important for drug discovery? Trends Pharmacol Sci 23 (5):225-231
20. Haefner B (2003) Drugs from the deep: marine natural products as drug candidates. Drug Discov Today 8 (12):536-544
21. NOAA Central Library (2013) Sea squirt. Http://www.lib.noaa.gov/retiredsites/korea/main_ species/sea_squirt.htm. Accessed 29 Oct 2013
22. Kim SM (2011) Antioxidant and anticancer activities of enzymatic hydrolysates of solitary tunicate (Styela clava). Food Sci Biotechnol 20 (4):1075-1085
23. Ryan JT, Ross RP, Bolton D et al (2011) Bioactive peptides from muscle sources: meat and fish. Nutrients 3 (9):765-791
24. Suarez-Jimenez GM, Burgos-Hernandez A, Ezquerra-Brauer JM (2012) Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals. Mar Drugs 10 (5):963-986
25. Cooper EL (2010) eCAM: retaining an international perspective. Evid Based Complement Alternat Med 7(4):397
26. Goldrosen MH, Straus SE (2004) Complementary and alternative medicine: assessing the evidence for immunological benefits. Nat Rev Immunol 4:912-921
27. Jimenez PC, Wilke DV, Takeara R et al (2008) Cytotoxic activity of a dichloromethane extract and fractions obtained from Eudistoma vannamei (Tunicata: Ascidiacea). Comp Bio- chem Physiol A Mol Integr Physiol 151 (3):391-398
28. Takeara R, Jimenez PC, Wilke DV et al (2008) Antileukemic effects of Didemnum psam- matodes (Tunicata: Ascidiacea) constituents. Comp Biochem Physiol A Mol Integr Physiol 151 (3):363-369
29. Sung PJ, Lin MR, Chen JJ et al (2007) Hydroperoxysterols from the tunicate Eudistoma sp. Chem Pharm Bull 55 (4):666-668
30. Fedorov SN, Radchenko OS, Shubina LK et al (2006) Evaluation of cancer-preventive activity and structure-activity relationships of 3-demethylubiquinone Q2, isolated from the ascid- ian Aplidium glabrum, and its synthetic analogs. Pharm Res 23 (1):70-81
31. Rashid MA, Gustafson KR, Boyd MR (2001) New cytotoxic N-methylated beta-carboline alkaloids from the marine ascidian Eudistoma gilboverde. J Nat Prod 64 (11):1454-1456
32. Oda T, Kamoshita K, Maruyama S et al (2007) Cytotoxicity of lissoclibadins and lissoclino- toxins, isolated from a tropical ascidian Lissoclinum cf. Badium, against human solid-tumor- derived cell lines. Biol Pharm Bull 30 (2):385-387
33. Manzanares I, Cuevas C, Garcia-Nieto R et al (2001) Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anticancer agents. Curr Med Chem Anticancer Agent 1 (3):257-276
34. Urdiales J, Morata P, De Castro IN, Sánchez-Jiménez F (1996) Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates. Cancer lett 102 (1):31-37
35. Appleton DR, Page MJ, Lambert G et al (2002) Kottamides AD: novel bioactive imidazo- lone-containing alkaloids from the New Zealand ascidian Pycnoclavella kottae. J Org Chem 67 (15):5402-5404
36. Xu CX, Jin H, Chung YS et al (2008) Chondroitin sulfate extracted from ascidian tunic inhibits phorbol ester-induced expression of inflammatory factors VCAM-1 and COX-2 by blocking NF-kB activation in mouse skin. J Agric Food Chem 56 (20):9667-9675
37. Depenbrock H, Peter R, Faircloth GT, Manzanares I, Jimeno J, Hanauske AR (1998) In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clo- nogenic human tumour cells and haematopoietic precursor cells. Br J Cancer 78(6):739
38. Reichardt P (2013) Current questions in soft tissue sarcoma: further steps with Yondelis®. Expert Rev Anticancer Ther 13:25-30
39. Le Tourneau C, Raymond E, Faivre S (2007) Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison. Curr Pharm Des 13 (33):3427-3439
40. Monk BJ, Herzog TJ, Kaye S et al (2010) Trabectedin plus pegylated liposomal doxorubicin in recurrent ovarian cancer. J Clin Oncol 28 (19):3107-3114
41. Twelves C, Hoekman K, Bowman A et al (2003) Phase I and pharmacokinetic study of Yondelis™(ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours. Eur J Cancer 39 (13):1842-1851
42. D’Incalci M, Jimeno J (2003) Preclinical and clinical results with the natural marine product ET-743. Expert Opin Investig Drugs 12:1843-1853
43. Schoffski P, Dumez H, Wolter P et al (2008) Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma. Expert Opin Pharmacother 9:1609-1618
44. Poveda A (2011) Introduction. Int J of Gynecol Cancer 21 (10):S1-S2
45. Xu Y, Kersten RD, Nam SJ et al (2012) Bacterial biosynthesis and maturation of the didemnin anti-cancer agents. J Am Chem Soc 134 (20):8625-8632
46. Baker DD, Alvi KA (2004) Small-molecule natural products: new structures, new activities. Curr Opin Biotechnol 15:576-583
47. Tsukimoto M, Nagaoka M, Shishido Y et al (2011) Bacterial production of the tunicate- derived antitumor cyclic depsipeptide didemnin B. J Nat Prod 74 (11):2329-2331
48. Carter NJ, Keam SJ (2010) Trabectedin: a review of its use in soft tissue sarcoma and ovarian cancer. Drugs 70:355-376